Brief: Glycomimetics Reports Highlights And Financial Results For Second Quarter 2022
03/08/2022 12:13
Aug 3 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS REPORTS HIGHLIGHTS AND FINANCIAL RESULTS FOR
SECOND QUARTER 2022
* GLYCOMIMETICS INC - THERE WAS MINIMAL REVENUE RECOGNIZED
DURING
THREE MONTHS ENDED JUNE 30, 2022 AND 2021
Source text for Eikon: ID:nBw9jCYnna
Further company coverage: GLYC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering